Search filters

List of works by Douglas L Arnold

Automatic Detection of Gadolinium-Enhancing Multiple Sclerosis Lesions in Brain MRI Using Conditional Random Fields ⬇️

scientific article published on February 3, 2012

Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study

scientific article published in September 2013

Comparison of Multiple Sclerosis Cortical Lesion Types Detected by Multicontrast 3T and 7T MRI

scientific article published on 20 June 2019

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis

scientific article published on October 2015

Effect of fingolimod on MRI outcomes in patients with paediatric-onset multiple sclerosis: results from the phase 3 PARADIGMS study

scientific article published on 04 March 2020

Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study

scientific article

Factors associated with emotional and behavioral outcomes in adolescents with multiple sclerosis ⬇️

scientific article published on January 30, 2012

Large, Nonplateauing Relationship Between Clinical Disability and Cerebral White Matter Lesion Load in Patients With Multiple Sclerosis ⬇️

scientific article published on January 1, 2012

Magnetic Resonance Spectroscopy in Epilepsy: Clinical Issues

scientific article published on 6 February 2002

Magnetic resonance techniques for the in vivo assessment of multiple sclerosis pathology: consensus report of the white matter study group.

scientific article

Magnetization transfer ratio in the delayed-release dimethyl fumarate DEFINE study

scientific article

Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis

scientific article published on 18 April 2020

No evidence of disease activity (NEDA) analysis by epochs in patients with relapsing multiple sclerosis treated with ocrelizumab vs interferon beta-1a

scientific article published in January 2018

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

scientific article published on 21 December 2016

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

scientific article published on 21 December 2016

Patterning Chronic Active Demyelination in Slowly Expanding/Evolving White Matter MS Lesions

scientific article published on 20 August 2020

Phase III dose‐comparison study of glatiramer acetate for multiple sclerosis ⬇️

scientific article published on January 1, 2011

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis ⬇️

scientific article published on September 20, 2012

Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity? ⬇️

scientific article published on February 11, 2012

Propagating Uncertainty Across Cascaded Medical Imaging Tasks for Improved Deep Learning Inference

scientific article published in 2022

Quality of life outcomes with BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: the DEFINE study

scientific article

Segmentation of magnetization transfer ratio lesions for longitudinal analysis of demyelination and remyelination in multiple sclerosis ⬇️

scientific article published on October 27, 2012

Silent new brain MRI lesions in children with MOG-antibody associated disease

scientific article published on 19 November 2020

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

scientific article published on 22 March 2018

Temporally Consistent Probabilistic Detection of New Multiple Sclerosis Lesions in Brain MRI ⬇️

scientific article published on April 16, 2013

Paulina is supported by:

About Paulina

Help